Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis.

ABSTRACT:

Background

The COVID-19 has caused significant mortality and morbidity across the globe. Patients with cancer are especially vulnerable given their immunocompromised state. We aimed to determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA).

Methods

Systematic review was performed through online databases, PubMed, Medline and Google Scholar, with keywords listed in the Methods section (1 November 2019-31 December 2020). Studies with clinical outcomes of at least 10 COVID-19 patients and at least one with a diagnosis of cancer were included. The studies for MA were assessed with PRISMA guidelines and appraised with Newcastle-Ottawa Scale. The data were pooled using a random-effects mod

SUBMITTER: Han S 

PROVIDER: S-EPMC8822543 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature